Watch Ticker

Enanta Pharmaceuticals, Inc

Go to Enanta Pharmaceuticals, Inc Website

$7.00

-0.13 (-1.76%)

Live

Previous Close

$7.12

Day Range

$6.95 - $7.19

Previous Day Range

$7.12 - $7.52

Market Cap

$158.4 million USD

Day Vol.

58206

Previous Day Vol.

99150

Currency

USD

Primary Exchange

Nasdaq

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Vandana Singh - FDA Expands AbbVie's Mavyret Label To Include Acute Hepatitis C Treatment (CORRECTED)

The FDA has approved a label expansion for AbbVie's Mavyret to include the treatment of acute hepatitis C virus (HCV) infection in patients without cirrhosis or with compensated cirrhosis. Mavyret has shown a 96% cure rate in an 8-week treatment with mostly mild side effects.

Related tickers: ABBV, ENTA.

Read Full Article

Delveinsight - Urticaria Clinical Trial Pipeline Accelerates: 20+ Leading Companies Pioneering New Treatments | DelveInsight

The urticaria pipeline is rapidly expanding, with over 20 leading companies developing 25+ new treatments to address the rising prevalence of the condition. Advances in biologic therapies and a strong R&D pipeline are driving progress, while improved healthcare infrastructure and digital innovations enhance patient access and outcomes.

Related tickers: REGN, ALLK, KNSA, CLDX, ENTA.

Read Full Article

Trending Tickers

Please sign in to view